Remove Clinical Trials Remove Concentrates Remove Extraction Remove Pharmaceutical
article thumbnail

The Cannabis Cancer Connection

Project CBD

United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising. Note: In May 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.]

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Study From UNM Shows Full Spectrum Hemp Oil Effective in Treating Chronic Neuropathic Pain

MedicalJane

The UNM researchers set out to examine the effectiveness of consuming “legal” hemp oil extracted from the whole Cannabis plant. This allowed the researchers to examine how “full-spectrum” whole plant extracted hemp oil influences brief episodes of pain sensitivity to an affected region. Westlund, Department of Anesthesiology.

Oil 100
article thumbnail

Cannabis-derived CBD catches on in Hong Kong, but 3 arrested after banned substances were found in products. most wrongly labelled products were US sourced

Cannabis Law Report

It is difficult to get 100 per cent pure CBD extracts from cannabis, and there’s a chance the products will contain traces of THC or other substances,” the source said. Any products that contain THC or other dangerous drugs at any level of concentration will be considered dangerous drugs under the law.”.

article thumbnail

The FDA’s Stance on Hemp-Derived CBD as a Dietary Supplement (Part 1)

Canna Law Blog

” After all, it is is a concentrate of a botanical: hemp. For example, two such substantial clinical investigations include GW Pharmaceuticals’ investigations regarding Sativex and Epidiolex. 21 U.S.C. § Hemp-CBD appears to makes the most sense as “dietary supplement.”

Hemp 95
article thumbnail

Gb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facility

Cannabis Law Report

“We can now concentrate all our energies on advancing our plant-inspired, biopharmaceutical research and development programs into human clinical trials.” ” Gb Sciences’ intellectual property portfolio includes five U.S. 31, 2021.

article thumbnail

World Medical Marijuana Cannabidiol Pipeline Report 2021 Published

Cannabis Law Report

Lenabasum: Corbus Pharmaceuticals Corbus Pharmaceuticals is developing Lenabasum, and currently it is in phase III stage of development for the treatment of multiple indications, such as dermatomyositis, systemic scleroderma, cystic fibrosis, systemic lupus erythematosus etc. Corbus Pharmaceuticals. TO Pharmaceuticals.